Clinical Trials

NCT03706833 | ACTIVE_NOT_RECRUITING | NA
1247 participants

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2018-11-30
Completion:
2026-06-30
Conditions
  • Degenerative Mitral Valve Disease
  • Mitral Regurgitation
  • Mitral Insufficiency
  • Functional Mitral Regurgitation
Interventions
  • DEVICE
No Results Yet
NCT03587311 | ACTIVE_NOT_RECRUITING | PHASE2
96 participants

Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2018-10-12
Completion:
2026-10-21
Conditions
  • Fallopian Tube Endometrioid Adenocarcinoma
  • Fallopian Tube High Grade Serous Adenocarcinoma
  • Ovarian Endometrioid Adenocarcinoma
  • Ovarian High Grade Serous Adenocarcinoma
  • Platinum-Resistant Fallopian Tube Carcinoma
  • Platinum-Resistant Ovarian Carcinoma
  • Platinum-Resistant Primary Peritoneal Carcinoma
  • Primary Peritoneal High Grade Serous Adenocarcinoma
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
NCT03269669 | ACTIVE_NOT_RECRUITING | PHASE2
73 participants

Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2018-01-23
Completion:
2025-12-31
Conditions
  • Grade 1 Follicular Lymphoma
  • Grade 2 Follicular Lymphoma
  • Grade 3a Follicular Lymphoma
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT03256773 | ACTIVE_NOT_RECRUITING
160 participants

High Resolution Micro OCT Imaging

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-08
Start Date:
2016-04-15
Completion:
2026-12-31
Conditions
  • Cystic Fibrosis
  • COPD
  • PCD - Primary Ciliary Dyskinesia
  • Covid19
  • Sinusitis
  • ILD
  • Normal Controls
No Results Yet
NCT02994719 | ACTIVE_NOT_RECRUITING
120 participants

Gait Analysis in Neurological Disease

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-08
Start Date:
2016-03-01
Completion:
2027-07-07
Conditions
  • Parkinson's Disease
  • Parkinsonian Disorders
  • Atypical Parkinson Disease
  • Progressive Supranuclear Palsy
  • Multiple System Atrophy
  • Corticobasal Degeneration
  • Gait, Frontal
  • Huntington Disease
  • Ataxia, Spinocerebellar
Interventions
  • DRUG
  • DEVICE
No Results Yet
NCT02650986 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
15 participants

Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2017-07-14
Completion:
2021-03-04
Conditions
  • Advanced Fallopian Tube Carcinoma
  • Advanced Malignant Solid Neoplasm
  • Advanced Melanoma
  • Advanced Ovarian Carcinoma
  • Advanced Primary Peritoneal Carcinoma
  • Advanced Synovial Sarcoma
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Fallopian Tube Carcinoma
  • Metastatic Melanoma
  • Metastatic Ovarian Carcinoma
  • Metastatic Primary Peritoneal Carcinoma
  • Metastatic Synovial Sarcoma
  • Pathologic Stage III Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIID Cutaneous Melanoma AJCC v8
  • Pathologic Stage IV Cutaneous Melanoma AJCC v8
  • Platinum-Resistant Fallopian Tube Carcinoma
  • Platinum-Resistant Ovarian Carcinoma
  • Platinum-Resistant Primary Peritoneal Carcinoma
  • Stage III Fallopian Tube Cancer AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Primary Peritoneal Cancer AJCC v8
  • Stage IIIA Fallopian Tube Cancer AJCC v8
  • Stage IIIA Ovarian Cancer AJCC v8
  • Stage IIIA Primary Peritoneal Cancer AJCC v8
  • Stage IIIA1 Fallopian Tube Cancer AJCC v8
  • Stage IIIA1 Ovarian Cancer AJCC v8
  • Stage IIIA2 Fallopian Tube Cancer AJCC v8
  • Stage IIIA2 Ovarian Cancer AJCC v8
  • Stage IIIB Fallopian Tube Cancer AJCC v8
  • Stage IIIB Ovarian Cancer AJCC v8
  • Stage IIIB Primary Peritoneal Cancer AJCC v8
  • Stage IIIC Fallopian Tube Cancer AJCC v8
  • Stage IIIC Ovarian Cancer AJCC v8
  • Stage IIIC Primary Peritoneal Cancer AJCC v8
  • Stage IV Fallopian Tube Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Primary Peritoneal Cancer AJCC v8
  • Stage IVA Fallopian Tube Cancer AJCC v8
  • Stage IVA Ovarian Cancer AJCC v8
  • Stage IVA Primary Peritoneal Cancer AJCC v8
  • Stage IVB Fallopian Tube Cancer AJCC v8
  • Stage IVB Ovarian Cancer AJCC v8
  • Stage IVB Primary Peritoneal Cancer AJCC v8
  • Unresectable Melanoma
  • Unresectable Ovarian Carcinoma
  • Unresectable Synovial Sarcoma
Interventions
  • DRUG
  • OTHER
  • PROCEDURE
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page